After Soaring 174% in 2025, Is Rocket Lab Stock a Buy in 2026?

Rocket Lab has seen a dramatic equity run (up ~360% in 2024 and ~174% in 2025) after securing an $816 million contract with the U.S. Space Development Agency and expanding its launch backlog to 49 missions. In its most recent quarter revenue hit a record $155 million (+48% YoY) with gross profit of $57.3 million and a 37% gross margin, though operating loss remained $58.9 million and net loss improved to $18.25 million ($0.03/share) from $51.93 million a year ago. The company closed a $325 million acquisition of Geost, is finalizing Mynaric, reported >$1 billion in liquidity, and is advancing its reusable Neutron vehicle toward a Q1 launch-platform milestone, signaling increased defense exposure and potential launch-velocity-driven revenue growth in 2026.

Analysis

Market structure: Rocket Lab (RKLB) is a clear winner — scale, a 49-launch backlog and 21 launches in 2025 give it pricing leverage with small-sat operators and a growing defense pipeline (SDA, NASA). Beneficiaries include RKLB, suppliers of composites/EO/laser comms (Geost/Mynaric acquirers) and defense primes that will integrate RKLB payloads; losers are marginal small-launchers and low-scale rideshare providers who cannot match cadence. Supply/demand signals point to tightening launch capacity for small satellites through 2026 (backlog conversion key), supporting higher realized pricing and improving gross margins (37% reported), with rising implied vol in RKLB options and modest downward pressure on sovereign long-duration yields if defense spending accelerates.

Risk assessment: Tail risks are binary and high-impact — a Neutron program failure or a major launch loss could erase >50% of market cap given recent rallies; export/ITAR issues from Mynaric/Geost integrations or SDA contract re-scoping are 5–15% probability, high cost. Immediate (days) moves will track contract/newsflow and short-term volatility; Q1 (weeks-months) is binary around Neutron platform transfer and any Neutron test announcement; long-term (12–36 months) hinges on converting backlog to revenue at sustaining margins and containing opex vs. liquidity (> $1bn).

Trade implications: Direct: establish a disciplined 2–3% long position in RKLB (size of portfolio) with a stop-loss 30% and a 12-month upside target of +60–100% if launch cadence and SDA awards proceed. Pair: long RKLB vs short thematic space ETF UFO (1:1 dollar neutral, reduce idiosyncratic sector noise) to capture execution alpha. Options: buy a 9–12 month call spread to cap premium (limit downside) sized 0.5–1.5% notional and buy short-dated puts (30–60 days) around Neutron events as hedges. Rotate: trim speculative small-cap space names and overweight defense primes (LMT, NOC, LHX or XAR) by +2–4% for 6–12 months.

Contrarian angles: The market may be underestimating concentration and integration risk — 49-launch backlog sounds robust but revenue conversion and margin delivery are not guaranteed; a 360%+ then 174% rally suggests momentum-fueled valuation stretched vs. fundamentals. If liquidity falls below ~$700m or launch cadence slips to <15/year in 2026, downside could be >40% as investors re-rate execution risk; conversely, a successful Neutron milestone in Q1 would likely justify a further re-rate, so trade sizing should be asymmetric around those binary catalysts.

Key Decisions for Investors

• Establish a 2–3% long position in RKLB (buy or equivalent exposure) within 30 days, target +60–100% in 12 months if launch cadence/backlog conversion holds; place a hard stop-loss at -30% and review position if consolidated liquidity falls below $700M or backlog drops under 40.
• Implement a dollar‑neutral pair: long RKLB vs short Procure Space ETF (UFO) sized 1:1 to isolate RKLB execution upside; rebalance after any >20% move in either leg and close within 6–12 months or on material Neutron news.
• Use options to express a bullish but defined-risk view: buy a 9–12 month RKLB call spread (size = 0.5–1.5% portfolio notional) to cap premium, and concurrently buy short-dated (30–60 day) puts costing ≤1% notional ahead of the Q1 Neutron platform test as tail protection.
• Rotate 4–6% of exposure from speculative small-cap space names into defense primes (Lockheed LMT, Northrop NOC, L3Harris LHX or XAR) over the next 30–90 days to capture SDA/DoD outsourcing; target a 6–12 month re-rate and reduce if government awards slow.
• Re-evaluate all positions on three catalysts: (1) Neutron platform/flight milestone expected in Q1, (2) any new SDA contract announcements in next 90 days, (3) quarterly liquidity and opex update — cut RKLB exposure by half if two of these three miss expectations.